Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients.

Palmerini E , Jones RL , Setola E , Picci P , Marchesi E , Luksch R , Grignani G , Cesari M , Longhi A , Abate ME , Paioli A , Szucs Z , D'ambrosio L , Scotlandi K , Fagioli F , Asaftei S , Ferrari S
Acta oncologica (Stockholm, Sweden)
Data on temozolomide (TEM) and irinotecan (IRI) activity in recurrent Ewing sarcoma (EWS), especially in adult patients, are limited.

Copyright(C) 2006 BIOIMPACT Co., Ltd. All Rights Reserved